Cite
MLA Citation
M. Ominsky et al.. “THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia.” Annals of the rheumatic diseases, vol. 72, 2013, pp. A299–A300. http://access.bl.uk/ark:/81055/vdc_100137793020.0x00005b